Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGIN

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

Buying momentum fuels share markets
Fri, 25 Jan 01:30 pm

Indian stock Markets, strengthened during the post noon trading session. Barring stocks in the oil and gas sector, buying activity was witnessed in stocks across the board. Stocks from the realty and auto spaces are amongst the top performers.

BSE-Sensex is up by 97 points and NSE-Nifty is trading up by 25 points. While BSE Mid Cap is trading up by 1.17%, BSE Small Cap index is trading up by 0.48%. The rupee is trading at 53.65 to the US dollar.

Most of the Pharma Stocks are trading in green with Glenmark and Strides Acrolab being among the top gainers. Lupin Ltd has announced that it has received USFDA approval for an oral contraceptive (OC) drug Lovonogestrel tablets USP 0.75mg. The product is a generic version of Teva's drug known by the brand name Plan B. The market size of this drug is USD 81m in US. It is pertinent to note, that company has achieved two OC drug approvals in a week's time taking its total approvals to eight now. Company has already launched six OCs as on date. Lupin has filed approx 30 ANDAs in the OC space so far. The OC market in the US is valued at over USD 5 bn and growing at around 8% per annum. The stock is trading up by 1%.

Majority of the Energy stocks are trading in green with Essar Oil and Hindustan Petroleum Corp Ltd being among the gainers. As per a leading financial daily, Reliance Industries (RIL) has put the sale of its textile unit including the iconic brand 'Only Vimal' on the backburner. The development comes due to lack of attractive offers in a challenging business environment for textiles. Reasons such as labour troubles and cyclicality of the textile business had forced RIL to put its textile business on the block. The textile unit contributes less than 1% to the company's consolidated sales with 90% of its revenues contributed by refining and petrochemicals business. However, lack of attractive offers has forced RIL to reconsider selling the business at least for the time being. The stock was trading down by 0.5%.

For information on how to pick stocks that have the potential to deliver big returns, download our special report now!

View all commentaries | Archives

Read the latest Market Commentary


Equitymaster requests your view! Post a comment on "Buying momentum fuels share markets". Click here!

  
ABOUT EQUITYMASTER

Since 1996, Equitymaster has been the source for honest and credible opinions on investing in India. With solid research and in-depth analysis Equitymaster is dedicated towards making its readers- smarter, more confident and richer every day. Here's why hundreds of thousands of readers spread across more than 70 countries Trust Equitymaster.

PREMIUM PRODUCTS
QUICK LINKS
POPULAR TOPICS
TRENDING TOPICS
FREE NEWSLETTERS
EQUITYMASTER SUPPORTS
  • HelpYourNGO
  • You Tube
  • Linkedin
  • Twitter
  • Telegram
  • Google Play

Copyright © Equitymaster Agora Research Private Limited.

Whitelist | Refer | Terms | Privacy | Contact | About | Sitemap

Phone +91-9136015013

Equitymaster Agora Research Private Limited (Research Analyst)
SEBI (Research Analysts) Regulations 2014, Registration No. INH000000537.

103, Regent Chambers, Above Status Restaurant, Nariman Point, Mumbai - 400 021. India.
Telephone: +91-22-61434055. Email: info@equitymaster.com. Website: www.equitymaster.com.
CIN:U74999MH2007PTC175407

Name of the Compliance & Grievance Officer: Ms Sonal Ramachandran
Telephone: +91-22-61434003 | Email: compliance@equitymaster.com

LEGAL DISCLAIMER:
Investment in securities market are subject to market risks. Read all the related documents carefully before investing.
Registration granted by SEBI and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.

All rights reserved. Any act of copying, reproducing or distributing this newsletter whether wholly or in part, for any purpose without the permission of Equitymaster is strictly prohibited and shall be deemed to be copyright infringement.

Equitymaster Agora Research Private Limited (Research Analyst) bearing Registration No. INH000000537 (hereinafter referred as 'Equitymaster') is an independent equity research Company. Equitymaster is not an Investment Adviser. Information herein should be regarded as a resource only and should be used at one's own risk. This is not an offer to sell or solicitation to buy any securities and Equitymaster will not be liable for any losses incurred or investment(s) made or decisions taken/or not taken based on the information provided herein. Information contained herein does not constitute investment advice or a personal recommendation or take into account the particular investment objectives, financial situations, or needs of individual subscribers. Before acting on any recommendation, subscribers should consider whether it is suitable for their particular circumstances and, if necessary, seek an independent professional advice. This is not directed for access or use by anyone in a country, especially, USA, Canada or the European Union countries, where such use or access is unlawful or which may subject Equitymaster or its affiliates to any registration or licensing requirement. All content and information is provided on an 'As Is' basis by Equitymaster. Information herein is believed to be reliable but Equitymaster does not warrant its completeness or accuracy and expressly disclaims all warranties and conditions of any kind, whether express or implied. Equitymaster may hold shares in the company/ies discussed herein. As a condition to accessing Equitymaster content and website, you agree to our Terms and Conditions of Use, available here. The performance data quoted represents past performance and does not guarantee future results.